The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
In this study, a comparative analysis of metal-related neuronal vulnerability was performed in two brainstem nuclei, the locus coeruleus (LC) and substantia nigra (SN), known targets of the etiological noxae in Parkinson's disease and related disorders. LC and SN pars compacta neurons both degenerate in Parkinson's disease and other Parkinsonisms; however, LC neurons are comparatively less affected and with a variable degree of involvement. In this study, iron, copper, and their major molecular forms like ferritins, ceruloplasmin, neuromelanin (NM), manganese-superoxide dismutase (SOD), and copper/zinc-SOD were measured in LC and SN of normal subjects at different ages. Iron content in LC was much lower than that in SN, and the ratio heavy-chain ferritin/iron in LC was higher than in the SN. The NM concentration was similar in LC and SN, but the iron content in NM of LC was much lower than SN. In both regions, heavy- and light-chain ferritins were present only in glia and were not detectable in neurons. These data suggest that in LC neurons, the iron mobilization and toxicity is lower than that in SN and is efficiently buffered by NM. The bigger damage occurring in SN could be related to the higher content of iron. Ferritins accomplish the same function of buffering iron in glial cells. Ceruloplasmin levels were similar in LC and SN, but copper was higher in LC. However, the copper content in NM of LC was higher than that of SN, indicating a higher copper mobilization in LC neurons. Manganese-SOD and copper/zinc-SOD had similar age trend in LC and SN. These results may explain at least one of the reasons underlying lower vulnerability of LC compared to SN in Parkinsonian syndromes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Locus coeruleus neurons contain norepinephrine-derived neuromelanin (227, 228); the dorsal motor nucleus of vagus contains neuromelanin that may be dopaminergic (202); and the raphe nuclei contain neuromelanin derived from their neurotransmitter, serotonin.”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [228]
In the citing paper
“In healthy ageing, selective accumulation of iron occurs in several brain regions and cell types, with iron mainly bound within ferritin and neuromelanin (panel).5,6”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“Neuromelanin is present in neurons as neuromelanin-iron complexes in which the iron content varies depending on the neurons in each brain area.6,53”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“Regional distribution of total iron in a healthy adult brain is heterogeneous; the highest iron concentrations were detected in the basal ganglia (putamen, globus pallidus, and caudate nucleus), whereas low concentrations were detected in the cortical grey matter, white matter, midbrain, and cerebellum, and the lowest iron concentrations were in the pons, locus coeruleus, and medulla.6,43,45–47”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“In the substantia nigra, ferritin heavy chain and ferritin light chain concentrations increase with age, whereas these are constant in the locus coeruleus; therefore iron could contribute to neurodegeneration in the substantia nigra more than in the locus coeruleus.5,6”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,002
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 752
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease
Paulus, W., & Jellinger, K. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00006 · Cited by 554
Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome
Connor, J. R., Boyer, P. J., Menzies, S. L., Dellinger, B., Allen, R. P., Ondo, W. G., & Earley, C. J. (2003) · Neurology · doi:10.1212/01.wnl.0000078887.16593.12 · Cited by 548
Curtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537
Disease‐specific patterns of locus coeruleus cell loss
German, D. C., Manaye, K. F., White, C. L., Woodward, D. J., McIntire, D. D., Smith, W. K., Kalaria, R. N., & Mann, D. M. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320510 · Cited by 512
Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells
Crichton, R. R., Wilmet, S., Legssyer, R., & Ward, R. J. (2002) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(02)00461-0 · Cited by 495
Chan‐Palay, V., & Asan, E. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902870308 · Cited by 495
Nygren, L.-G., & Olson, L. (1977) · Brain Research · doi:10.1016/0006-8993(77)90707-7 · Cited by 493
Effects of putative neurotransmitters on neuronal activity in monkey auditory cortex
Foote, S. L., Freedman, R., & Oliver, A. P. (1975) · Brain Research · doi:10.1016/0006-8993(75)90699-x · Cited by 458
A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra
Saggu, H., Cooksey, J., Dexter, D., Wells, F. R., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11759.x · Cited by 454
Sulzer, D., Bogulavsky, J., Larsen, K. E., Behr, G., Karatekin, E., Kleinman, M. H., Turro, N., Krantz, D., Edwards, R. H., Greene, L. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.11869 · Cited by 407
Self-citationZecca, L., Gallorini, M., Schünemann, V., Trautwein, A. X., Gerlach, M., Riederer, P., Vezzoni, P., & Tampellini, D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00186.x · Cited by 401
Self-citationCeruloplasmin regulates iron levels in the CNS and prevents free radical injury
Patel, B. N., Dunn, R. J., Jeong, S. Y., Zhu, Q., Julien, J.-P., & David, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06578.2002 · Cited by 379
Brain iron pathways and their relevance to Parkinson's disease
Berg, D., Gerlach, M., Youdim, M. B. H., Double, K. L., Zecca, L., Riederer, P., & Becker, G. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00608.x · Cited by 362
Self-citationWilms, H., Rosenstiel, P., Sievers, J., Deuschl, G., Zecca, L., & Lucius, R. (2003) · The FASEB Journal · doi:10.1096/fj.02-0314fje · Cited by 337
Self-citationConnor, J. R., Snyder, B. S., Arosio, P., Loeffler, D. A., & LeWitt, P. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020717.x · Cited by 317
Self-citationSelectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP + Binds to Neuromelanin
D'Amato, R. J., Lipman, Z. P., & Snyder, S. H. (1986) · Science · doi:10.1126/science.3080808 · Cited by 296
Zecca, L., Fariello, R., Riederer, P., Sulzer, D., Gatti, A., & Tampellini, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(01)03269-0 · Cited by 285
Self-citationZecca, L., Zucca, F. A., Wilms, H., & Sulzer, D. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.009 · Cited by 264
Self-citationMason, S. T., & Fibiger, H. C. (1979) · Journal of Comparative Neurology · doi:10.1002/cne.901870405 · Cited by 261
Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders
Loeffler, D. A., LeWitt, P. A., Juneau, P. L., Sima, A. A. F., Nguyen, H.-U., DeMaggio, A. J., Brickman, C. M., Brewer, G. J., Dick, R. D., Troyer, M. D., et al. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00782-2 · Cited by 236
Chronic Manganese Intoxication
Cook, D. G., Fahn, S., & Brait, K. A. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490310061010 · Cited by 229
Interaction of neuromelanin and iron in substantia nigra and other areas of human brain
Zecca, L., Shima, T., Stroppolo, A., Goj, C., Battiston, G. A., Gerbasi, R., Sarna, T., & Swartz, H. M. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00047-4 · Cited by 196
Self-citationMPTP: a review of its mechanisms of neurotoxicity
Przedborski, S., & Vila, M. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00019-6 · Cited by 191
The structure of neuromelanin as studied by chemical degradative methods
Wakamatsu, K., Fujikawa, K., Zucca, F. A., Zecca, L., & Ito, S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01917.x · Cited by 172
Self-citationIron and Other Metals in Neuromelanin, Substantia Nigra, and Putamen of Human Brain
Zecca, L., Pietra, R., Goj, C., Mecacci, C., Radice, D., & Sabbioni, E. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031097.x · Cited by 163
Self-citationShima, T., Sarna, T., Swartz, H. M., Stroppolo, A., Gerbasi, R., & Zecca, L. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00623-5 · Cited by 146
Self-citationTotal and paramagnetic metals in human substantia nigra and its neuromelanin
Zecca, L., & Swartz, H. M. (1993) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257675 · Cited by 133
Self-citationHoogendijk, W. J. G., Pool, C. W., Troost, D., van Zwieten, E. J., & Swaab, D. F. (1995) · Brain · doi:10.1093/brain/118.1.131 · Cited by 132
The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems
Zaręba, M., Bober, A., Korytowski, W., Zecca, L., & Sarna, T. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00058-c · Cited by 131
Self-citationKalivendi, S. V., Kotamraju, S., CUNNINGHAM, S., Shang, T., Hillard, C. J., & Kalyanaraman, B. (2003) · Biochemical Journal · doi:10.1042/bj20021525 · Cited by 128
Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: Accumulation in neuromelanin
Lindquist, N. G., Larsson, B. S., & Lydén‐Sokolowski, A. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90002-x · Cited by 115
Grünblatt, E., Mandel, S. A., & Youdim, M. B. H. (2000) · Journal of Neurology · doi:10.1007/pl00022909 · Cited by 109
Interaction of Human Substantia Nigra Neuromelanin with Lipids and Peptides
Zecca, L., Costi, P., Mecacci, C., Ito, S., Terreni, M., & Sonnino, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741758.x · Cited by 95
Self-citationLee, J.-W. (2000) · Archives of Neurology · doi:10.1001/archneur.57.4.597 · Cited by 76
Studies on neuromelanin: II. Melanin in the brainstems of infants and children
Fenichel, G. M., & Bazelon, M. (1968) · Neurology · doi:10.1212/wnl.18.8.817 · Cited by 62
An Overview of Iron Metabolism: Molecular and Cellular Criteria for the Selection of Iron Chelators
Crichton, R. R., & Ward, R. J. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457566 · Cited by 48
Noradrenergic mechanisms in age-related cognitive decline.
Arnsten, A. F. T., & Goldman-Rakic, P. S. (1987) · PubMed · Cited by 38
Kunikowska, G., & Jenner, P. G. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02240-6 · Cited by 37
Berg, D., Weishaupt, A., Francis, M. J., Miura, N., Yang, X., Goodyer, I. D., Naumann, M. K., Koltzenburg, M., Reiners, K., & Becker, G. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200006)47:6<827::aid-ana20>3.0.co;2-h · Cited by 36
Rego, A. C., Monteiro, N. M., Silva, A. P., Gil‐Mohapel, J., Malva, J. O., & Oliveira, C. R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01898.x · Cited by 24
Copper-containing monooxygenases: enzymatic and biomimetic studies of the O-atom transfer catalysis
Blain, I., Slama, P. S., Giorgi, M., Tron, T., & Réglier, M. (2002) · Reviews in Molecular Biotechnology · doi:10.1016/s1389-0352(01)00068-x · Cited by 23
Superoxide dismutase-like activity in the Parkinson's disease brain.
Rj, M., Viljanen, M., Toivonen, E., Lorentz, H., & Rinne, U. K. (1990) · PubMed · Cited by 11
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Research works printed but not linked: 5
- Arnsten, A. F. & Goldman-Rakic, P. S. (1987) J. Neural Transm. 24, 317-324.
- 10.1002/1531-8249(199910)46:4<598::aid-ana7>3.0.co;2-f · DOI
- Wilms, H., Rosenstiel, P., Sievers, J., Deuschl, G., Zecca, L. & Lucius, R. (2003) FASEB J. 17, 500-502.12631585
- Blain, I., Slama, P., Giorgi, M., Tron, T. & Reglier, M. (2002) J. Biotechnol. 90, 95-112.12069196
- Marttila, R. J., Viljanen, M., Toivonen, E., Lorentz, H. & Rinne, U. K. (1990) Adv. Neurol. 53, 141-144.2239455
Cited by
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
Que, E. L., Domaille, D. W., & Chang, C. J. (2008) · Chemical Reviews · doi:10.1021/cr078203u · Cited by 2,061
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Self-citationIron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
Self-citationInteractions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
Self-citationIron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Belaidi, A. A., & Bush, A. I. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13425 · Cited by 578
Metadata
- Authors
- Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., Karatekin, E., Kleinman, M. H., Turro, N., Hornykiewicz, O., & Zucca, F. A.
- Affiliations
- Institute of Biomedical Technologies (IT)
- University of Vienna (AT)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-06-21
- Volume
- 101
- Issue
- 26
- Pages
- 9843-9848
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC470762
- OpenAlex
- W2116294955
- Cited by
- 495
- References
- 51
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 31 · 2023: 30 · 2022: 37 · 2021: 46 · 2020: 31 · 2019: 41 · 2018: 23 · 2017: 18 · 2016: 21 · 2015: 22 · 2014: 18 · 2013: 14 · 2012: 21
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- iron, copper, locus coeruleus, substantia nigra, Parkinson's disease, neuronal vulnerability, aging, neuromelanin, ferritin, ceruloplasmin, manganese superoxide dismutase, copper-zinc superoxide dismutase, iron mobilization, iron toxicity, brainstem
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aging, Ceruloplasmin, Copper, Electron Spin Resonance Spectroscopy, Female, Ferritins, Homeostasis, Humans, Iron, Iron Chelating Agents, Locus Coeruleus, Male, Melanins, Middle Aged, Neuroglia, Neurons, Substantia Nigra, Superoxide Dismutase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.